Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 17.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 13,890 shares of the pharmacy operator’s stock after selling 2,944 shares during the period. SeaCrest Wealth Management LLC’s holdings in Walgreens Boots Alliance were worth $347,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in WBA. Vontobel Holding Ltd. grew its holdings in Walgreens Boots Alliance by 104.6% during the 1st quarter. Vontobel Holding Ltd. now owns 36,922 shares of the pharmacy operator’s stock worth $1,752,000 after acquiring an additional 18,879 shares in the last quarter. Moors & Cabot Inc. grew its holdings in Walgreens Boots Alliance by 31.1% during the 1st quarter. Moors & Cabot Inc. now owns 20,791 shares of the pharmacy operator’s stock worth $931,000 after acquiring an additional 4,931 shares in the last quarter. Sequoia Financial Advisors LLC grew its holdings in Walgreens Boots Alliance by 27.9% during the 1st quarter. Sequoia Financial Advisors LLC now owns 7,569 shares of the pharmacy operator’s stock worth $339,000 after acquiring an additional 1,651 shares in the last quarter. Candriam Luxembourg S.C.A. grew its holdings in Walgreens Boots Alliance by 0.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after acquiring an additional 310 shares in the last quarter. Finally, Baird Financial Group Inc. grew its holdings in Walgreens Boots Alliance by 14.2% during the 1st quarter. Baird Financial Group Inc. now owns 467,533 shares of the pharmacy operator’s stock worth $20,932,000 after acquiring an additional 58,184 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

WBA stock opened at $21.69 on Friday. The company has a fifty day moving average price of $21.71 and a 200 day moving average price of $22.27. Walgreens Boots Alliance, Inc. has a 12 month low of $19.68 and a 12 month high of $36.58. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.50.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last released its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, beating the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter in the prior year, the firm earned $1.16 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 6.3% on a year-over-year basis. Equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.25 EPS for the current fiscal year.

Walgreens Boots Alliance Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 12th. Shareholders of record on Tuesday, February 20th were given a dividend of $0.25 per share. The ex-dividend date was Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 4.61%. Walgreens Boots Alliance’s payout ratio is currently -14.29%.

Insiders Place Their Bets

In other news, CEO Timothy C. Wentworth acquired 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The stock was bought at an average price of $24.22 per share, for a total transaction of $242,200.00. Following the transaction, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 15,209 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $23.05, for a total transaction of $350,567.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Timothy C. Wentworth purchased 10,000 shares of the stock in a transaction dated Friday, January 5th. The shares were bought at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the completion of the purchase, the chief executive officer now owns 585,122 shares in the company, valued at $14,171,654.84. The disclosure for this purchase can be found here. 17.40% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research firms have commented on WBA. Barclays began coverage on shares of Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target for the company. TheStreet upgraded shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. Morgan Stanley lowered their target price on shares of Walgreens Boots Alliance from $22.00 to $21.00 and set an “underweight” rating for the company in a report on Tuesday, March 26th. HSBC restated a “reduce” rating and issued a $20.00 target price (down previously from $27.00) on shares of Walgreens Boots Alliance in a report on Tuesday, February 20th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $25.00.

Read Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.